About Ratio TherapeuticsRatio Therapeutics is committed to improving and extending the lives of cancer patients without sacrificing their quality of life. We are a team of passionate scientists, engineers, and business professionals dedicated to advancing the field of targeted radioligand therapy. To accomplish this, we utilize our proprietary TRILLIUM and MACROPA platforms: TRILLIUM allows fine-tuning of radioligand pharmacokinetics thereby enhancing the therapeutic index, while MACROPA ...
Insert additional messaging here.
